logo-black-conderco

INTERMEDIATE

We provide products intended for their subsequent commercialization.

Product List

  • 1,3,5-Tri-O-acetyl-2-deoxy-D-erythro-pentofuranose CAS No.4594-52-9
  • 1,3,5-Tri-O-acetyl-2-deoxy-alpha-D-erythro-pentofuranose CAS No.96291-74-6
  • 1-O-Acetyl-3,5-Bis-(4-Chlorobenzoyl)-2-Deoxy-D-Ribose
  • 1-Chloro-3,5-di(4-chlorbenzoyl)-2-deoxy-D-ribose CAS No.3601-90-9
  • 1-Chloro-3,5-di-(4-chlorobenzoyl)-2-deoxy-D-ribose CAS No.21740-23-8
  • 1-Chloro-3,5-di-O-toluoyl-2-deoxy-D-ribofuranose CAS No.3601-89-6

Gemcitabine Intermediates:

  • Ethyl (3R,S)-2,2-difluoro-3-hydroxy-3-(2,2-dimethyldioxolan-4-yl)propionate CAS No.95058-92-7
  • 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate CAS No.122111-01-7
  • 2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate CAS No.143157-22-62-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate CAS No.122111-11-9
  • 2′,2′-Difluoro-2′-deoxycytidine-3′,5′-dibenzoate CAS No.134790-39-9Clorfarabine intermediates
  • 1-o-acetyl-2,3,5-tri-o-benzoyl-beta-d-ribofuranose CAS No.6974-32-9 (70832-64-3)
  • 1,3,5-tri-o-benzoyl-d-ribofuranose CAS No.22224-41-
  • 2-deoxy-2-fluoro-1,3,5-tri-o-benzoyl-d-ribofuranose CAS No.97614-43-2
  • [(2R,3R,4S,5R)-3-(Benzoyloxy)-5-bromo-4-fluorooxolan-2-yl]methyl benzoate CAS No.97614-44-3
  • Ibandronate acidCAS No.114084-78-5

Pemetrexed Intermediates:

  • 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid CAS No. 137281-39-1
  • 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid methyl ester CAS No. 155405-80-4
  • N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]L-glutamic acid CAS No. 165049-28-5
  • N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid CAS No. 137281-23-3

Adefovir intermédiate:

  • Diethyl [(2-chloroethoxy)methyl]phosphonate CAS No.116384-56-6
  • Diethyl (tosyloxy)methylphosphonate CAS No.31618-90-3
  • [[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid diethyl ester CAS No.116384-53-3
  • 9-[2-Phosphonylmethoxyethyl]adenine(PMEA) CAS No.106941-25-7

    Adefovir dipivoxil CAS No.142340-99-6

  • 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid methyl ester CAS No. 155405-80-4
  • N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]L-glutamic acid CAS No. 165049-28-5
  • N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid CAS No. 137281-23-3

Entecavir Intermediate:

  • (1S-trans)-2-[(Phenylmethoxy)methyl]-3-cyclopenten-1-ol CAS No.110567-21-0(1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane CAS No.110567-22-1
  • (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol CAS No.142217-77-4
  • (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol CAS No.142217-78-5
  • 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine CAS No.142217-80-9
  • 6-(Benzyloxy)-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-9H-purine-2-amine CAS No.204845-95-4
  • 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one CAS No.142217-81-0
  • Entecavir;2-Amino-1,9-dihydro-9-[(1s,3r,4s)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one CAS No.142217-69-4

Tenofovir Intermediate:

  • 1-(6-Aminopurin-9-yl)propan-2-yloxymethylphosphonic acid CAS No.147127-20-6
  • Rosuvastatina intermédiate
  • Z7:4-(4-Fluorophenyl)-6-isopropyl-2-[ (n-methyl-n-methylsulfonyl)amino ] pyrimidine-5-yl-methonol CAS No.147118-36-3
  • Z8:4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino] pyrimidinyl-5-yl-formyl CAS No.147118-37-4
  • 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine CAS No.799842-07-2
  • C4:(4R-cis)-6-[ (acetyloxy)methyl ]-2,2-dimethyl-1,3-dioxane-4-acetic acid,1,1-dimethylethyl ester CAS No.1540426-95-6
  • C5:(4R-Cis)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic acid 1,1-dimethylethyl ester CAS No.124655-09-0

Ezetimibe intermédiate:

  • 4-(4-Fluorobenzoyl)butyric acid CAS No.149437-76-3
  • Methyl (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoate CAS No.204589-80-0

DAPOXETINA Intermédiate:

  • Dapoxetine hydrochloride ;(S-(+)-N,N-Dimethyl-a-[2-(naphthalenyloxy)ethyl]benzenemethanamine hydrochloride CAS No.119356-77-3

More products

API

Active Pharmaceutical Ingredient (API) is the core component of any medication that provides its therapeutic effect.

FINISHED FORM

We provide fractionated pharmaceutical products to companies in Latin America.